Global Meningococcal Vaccine Market Research Report 2023(Status and Outlook)

Global Meningococcal Vaccine Market Research Report 2023(Status and Outlook)



Report Overview

Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.

Global Meningococcal Vaccine key players include GSK, SANOFI PASTEUR S.A, Norvatis, Crucell, Medimmune, etc. Global top five players hold a share about 80%.

Europe is the largest market, with a share about 45%, followed by North America and China, having a total share about 40 percent.

In terms of product, Polysaccharide Meningtitis AC is the largest segment, with a share about 95%. And in terms of application, the largest application is 6 Months-15Year, followed by over 3 Year, over 2 Year, over 3 Months.

The Global Meningococcal Vaccine Market Size was estimated at USD 251.00 million in 2022 and is projected to reach USD 339.29 million by 2029, exhibiting a CAGR of 4.40% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Meningococcal Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Meningococcal Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Meningococcal Vaccine market in any manner.

Global Meningococcal Vaccine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Novartis

GSK

Merck

CSL

Baxter

JN International Medical Corporation

Serum Institute of India

Bio-Med

China National Biotec Group

Hualan Bio

Walvax

Zhifei

Market Segmentation (by Type)

Meningtits A

Polysaccharide Meningtitis AC

Meningitis ACYW

Market Segmentation (by Application)

Environmental Testing

Pharmaceutical

Food Industry

Chemical

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Meningococcal Vaccine Market

Overview of the regional outlook of the Meningococcal Vaccine Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Meningococcal Vaccine
1.2 Key Market Segments
1.2.1 Meningococcal Vaccine Segment by Type
1.2.2 Meningococcal Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Meningococcal Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Meningococcal Vaccine Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Meningococcal Vaccine Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Meningococcal Vaccine Market Competitive Landscape
3.1 Global Meningococcal Vaccine Sales by Manufacturers (2018-2023)
3.2 Global Meningococcal Vaccine Revenue Market Share by Manufacturers (2018-2023)
3.3 Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Meningococcal Vaccine Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Meningococcal Vaccine Sales Sites, Area Served, Product Type
3.6 Meningococcal Vaccine Market Competitive Situation and Trends
3.6.1 Meningococcal Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Meningococcal Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Meningococcal Vaccine Industry Chain Analysis
4.1 Meningococcal Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Meningococcal Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Meningococcal Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Meningococcal Vaccine Sales Market Share by Type (2018-2023)
6.3 Global Meningococcal Vaccine Market Size Market Share by Type (2018-2023)
6.4 Global Meningococcal Vaccine Price by Type (2018-2023)
7 Meningococcal Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Meningococcal Vaccine Market Sales by Application (2018-2023)
7.3 Global Meningococcal Vaccine Market Size (M USD) by Application (2018-2023)
7.4 Global Meningococcal Vaccine Sales Growth Rate by Application (2018-2023)
8 Meningococcal Vaccine Market Segmentation by Region
8.1 Global Meningococcal Vaccine Sales by Region
8.1.1 Global Meningococcal Vaccine Sales by Region
8.1.2 Global Meningococcal Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Meningococcal Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Meningococcal Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Meningococcal Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Meningococcal Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Meningococcal Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Novartis
9.1.1 Novartis Meningococcal Vaccine Basic Information
9.1.2 Novartis Meningococcal Vaccine Product Overview
9.1.3 Novartis Meningococcal Vaccine Product Market Performance
9.1.4 Novartis Business Overview
9.1.5 Novartis Meningococcal Vaccine SWOT Analysis
9.1.6 Novartis Recent Developments
9.2 GSK
9.2.1 GSK Meningococcal Vaccine Basic Information
9.2.2 GSK Meningococcal Vaccine Product Overview
9.2.3 GSK Meningococcal Vaccine Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Meningococcal Vaccine SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Merck
9.3.1 Merck Meningococcal Vaccine Basic Information
9.3.2 Merck Meningococcal Vaccine Product Overview
9.3.3 Merck Meningococcal Vaccine Product Market Performance
9.3.4 Merck Business Overview
9.3.5 Merck Meningococcal Vaccine SWOT Analysis
9.3.6 Merck Recent Developments
9.4 CSL
9.4.1 CSL Meningococcal Vaccine Basic Information
9.4.2 CSL Meningococcal Vaccine Product Overview
9.4.3 CSL Meningococcal Vaccine Product Market Performance
9.4.4 CSL Business Overview
9.4.5 CSL Meningococcal Vaccine SWOT Analysis
9.4.6 CSL Recent Developments
9.5 Baxter
9.5.1 Baxter Meningococcal Vaccine Basic Information
9.5.2 Baxter Meningococcal Vaccine Product Overview
9.5.3 Baxter Meningococcal Vaccine Product Market Performance
9.5.4 Baxter Business Overview
9.5.5 Baxter Meningococcal Vaccine SWOT Analysis
9.5.6 Baxter Recent Developments
9.6 JN International Medical Corporation
9.6.1 JN International Medical Corporation Meningococcal Vaccine Basic Information
9.6.2 JN International Medical Corporation Meningococcal Vaccine Product Overview
9.6.3 JN International Medical Corporation Meningococcal Vaccine Product Market Performance
9.6.4 JN International Medical Corporation Business Overview
9.6.5 JN International Medical Corporation Recent Developments
9.7 Serum Institute of India
9.7.1 Serum Institute of India Meningococcal Vaccine Basic Information
9.7.2 Serum Institute of India Meningococcal Vaccine Product Overview
9.7.3 Serum Institute of India Meningococcal Vaccine Product Market Performance
9.7.4 Serum Institute of India Business Overview
9.7.5 Serum Institute of India Recent Developments
9.8 Bio-Med
9.8.1 Bio-Med Meningococcal Vaccine Basic Information
9.8.2 Bio-Med Meningococcal Vaccine Product Overview
9.8.3 Bio-Med Meningococcal Vaccine Product Market Performance
9.8.4 Bio-Med Business Overview
9.8.5 Bio-Med Recent Developments
9.9 China National Biotec Group
9.9.1 China National Biotec Group Meningococcal Vaccine Basic Information
9.9.2 China National Biotec Group Meningococcal Vaccine Product Overview
9.9.3 China National Biotec Group Meningococcal Vaccine Product Market Performance
9.9.4 China National Biotec Group Business Overview
9.9.5 China National Biotec Group Recent Developments
9.10 Hualan Bio
9.10.1 Hualan Bio Meningococcal Vaccine Basic Information
9.10.2 Hualan Bio Meningococcal Vaccine Product Overview
9.10.3 Hualan Bio Meningococcal Vaccine Product Market Performance
9.10.4 Hualan Bio Business Overview
9.10.5 Hualan Bio Recent Developments
9.11 Walvax
9.11.1 Walvax Meningococcal Vaccine Basic Information
9.11.2 Walvax Meningococcal Vaccine Product Overview
9.11.3 Walvax Meningococcal Vaccine Product Market Performance
9.11.4 Walvax Business Overview
9.11.5 Walvax Recent Developments
9.12 Zhifei
9.12.1 Zhifei Meningococcal Vaccine Basic Information
9.12.2 Zhifei Meningococcal Vaccine Product Overview
9.12.3 Zhifei Meningococcal Vaccine Product Market Performance
9.12.4 Zhifei Business Overview
9.12.5 Zhifei Recent Developments
10 Meningococcal Vaccine Market Forecast by Region
10.1 Global Meningococcal Vaccine Market Size Forecast
10.2 Global Meningococcal Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Meningococcal Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Meningococcal Vaccine Market Size Forecast by Region
10.2.4 South America Meningococcal Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Meningococcal Vaccine by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Meningococcal Vaccine Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Meningococcal Vaccine by Type (2024-2029)
11.1.2 Global Meningococcal Vaccine Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Meningococcal Vaccine by Type (2024-2029)
11.2 Global Meningococcal Vaccine Market Forecast by Application (2024-2029)
11.2.1 Global Meningococcal Vaccine Sales (K MT) Forecast by Application
11.2.2 Global Meningococcal Vaccine Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings